Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
GET FREE SAMPLE REPORT :
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Prophylactic Human Vaccine industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Prophylactic Human Vaccine market can be split based on product types, major applications, and important countries as follows:
Key players in the global Prophylactic Human Vaccine market covered in Chapter 12:
Emergent BioSolutions
Biovac
Merial
GSK
McKesson Medical
Inovio Pharmaceuticals
Merck
Novavax
Sanofi
Zoetis
In Chapter 4 and 14.1, on the basis of types, the Prophylactic Human Vaccine market from 2015 to 2025 is primarily split into:
Inactivated Vaccine
Attenuated Vaccine
Others
In Chapter 5 and 14.2, on the basis of applications, the Prophylactic Human Vaccine market from 2015 to 2025 covers:
Cholera
Anthrax
Chicken pox
Rabies
Tetanus
SHARE YOUR QUERIES :
Tuberculosis
Influenza
Poliomyelitis
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
REPORT DETAILS:
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
TABLE OF CONTENT :
1 Prophylactic Human Vaccine Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Prophylactic Human Vaccine
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19’s impact on the Prophylactic Human Vaccine industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Prophylactic Human Vaccine Market Size, 2015 – 2020
2.1.2 Global Prophylactic Human Vaccine Market Size by Type, 2015 – 2020
2.1.3 Global Prophylactic Human Vaccine Market Size by Application, 2015 – 2020
2.1.4 Global Prophylactic Human Vaccine Market Size by Region, 2015 – 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Prophylactic Human Vaccine Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Prophylactic Human Vaccine Analysis
3.2 Major Players of Prophylactic Human Vaccine
3.3 Prophylactic Human Vaccine Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Prophylactic Human Vaccine
3.3.3 Labor Cost of Prophylactic Human Vaccine
3.4 Market Distributors of Prophylactic Human Vaccine
3.5 Major Downstream Buyers of Prophylactic Human Vaccine Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Prophylactic Human Vaccine Market, by Type
4.1 Global Prophylactic Human Vaccine Value and Market Share by Type (2015-2020)
4.2 Global Prophylactic Human Vaccine Production and Market Share by Type (2015-2020)
4.3 Global Prophylactic Human Vaccine Value and Growth Rate by Type (2015-2020)
4.3.1 Global Prophylactic Human Vaccine Value and Growth Rate of Inactivated Vaccine
4.3.2 Global Prophylactic Human Vaccine Value and Growth Rate of Attenuated Vaccine
4.3.3 Global Prophylactic Human Vaccine Value and Growth Rate of Others
4.4 Global Prophylactic Human Vaccine Price Analysis by Type (2015-2020)
5 Prophylactic Human Vaccine Market, by Application
5.1 Downstream Market Overview
5.2 Global Prophylactic Human Vaccine Consumption and Market Share by Application (2015-2020)
5.3 Global Prophylactic Human Vaccine Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Prophylactic Human Vaccine Consumption and Growth Rate of Cholera (2015-2020)
5.3.2 Global Prophylactic Human Vaccine Consumption and Growth Rate of Anthrax (2015-2020)
5.3.3 Global Prophylactic Human Vaccine Consumption and Growth Rate of Chicken pox (2015-2020)
5.3.4 Global Prophylactic Human Vaccine Consumption and Growth Rate of Rabies (2015-2020)
5.3.5 Global Prophylactic Human Vaccine Consumption and Growth Rate of Tetanus (2015-2020)
5.3.6 Global Prophylactic Human Vaccine Consumption and Growth Rate of Tuberculosis (2015-2020)
5.3.7 Global Prophylactic Human Vaccine Consumption and Growth Rate of Influenza (2015-2020)
5.3.8 Global Prophylactic Human Vaccine Consumption and Growth Rate of Poliomyelitis (2015-2020)
6 Global Prophylactic Human Vaccine Market Analysis by Regions
6.1 Global Prophylactic Human Vaccine Sales, Revenue and Market Share by Regions
6.1.1 Global Prophylactic Human Vaccine Sales by Regions (2015-2020)
6.1.2 Global Prophylactic Human Vaccine Revenue by Regions (2015-2020)
6.2 North America Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
6.3 Europe Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
6.6 South America Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
7 North America Prophylactic Human Vaccine Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Prophylactic Human Vaccine Sales, Revenue and Market Share by Countries
7.2.1 North America Prophylactic Human Vaccine Sales by Countries (2015-2020)
7.2.2 North America Prophylactic Human Vaccine Revenue by Countries (2015-2020)
7.3 United States Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
7.4 Canada Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
7.5 Mexico Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
8 Europe Prophylactic Human Vaccine Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Prophylactic Human Vaccine Sales, Revenue and Market Share by Countries
8.2.1 Europe Prophylactic Human Vaccine Sales by Countries (2015-2020)
8.2.2 Europe Prophylactic Human Vaccine Revenue by Countries (2015-2020)
8.3 Germany Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
8.4 UK Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
8.5 France Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
8.6 Italy Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
8.7 Spain Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
8.8 Russia Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
9 Asia Pacific Prophylactic Human Vaccine Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Prophylactic Human Vaccine Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Prophylactic Human Vaccine Sales by Countries (2015-2020)
9.2.2 Asia Pacific Prophylactic Human Vaccine Revenue by Countries (2015-2020)
9.3 China Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
9.4 Japan Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
9.5 South Korea Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
9.6 India Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
9.8 Australia Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
10 Middle East and Africa Prophylactic Human Vaccine Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Prophylactic Human Vaccine Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Prophylactic Human Vaccine Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Prophylactic Human Vaccine Revenue by Countries (2015-2020)
10.3 Saudi Arabia Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
10.4 UAE Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
10.5 Egypt Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
10.6 Nigeria Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
10.7 South Africa Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
11 South America Prophylactic Human Vaccine Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Prophylactic Human Vaccine Sales, Revenue and Market Share by Countries
11.2.1 South America Prophylactic Human Vaccine Sales by Countries (2015-2020)
11.2.2 South America Prophylactic Human Vaccine Revenue by Countries (2015-2020)
11.3 Brazil Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
11.4 Argentina Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
11.5 Columbia Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
11.6 Chile Prophylactic Human Vaccine Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 Emergent BioSolutions
12.1.1 Emergent BioSolutions Basic Information
12.1.2 Prophylactic Human Vaccine Product Introduction
12.1.3 Emergent BioSolutions Production, Value, Price, Gross Margin 2015-2020
12.2 Biovac
12.2.1 Biovac Basic Information
12.2.2 Prophylactic Human Vaccine Product Introduction
12.2.3 Biovac Production, Value, Price, Gross Margin 2015-2020
12.3 Merial
12.3.1 Merial Basic Information
12.3.2 Prophylactic Human Vaccine Product Introduction
12.3.3 Merial Production, Value, Price, Gross Margin 2015-2020
12.4 GSK
12.4.1 GSK Basic Information
12.4.2 Prophylactic Human Vaccine Product Introduction
12.4.3 GSK Production, Value, Price, Gross Margin 2015-2020
12.5 McKesson Medical
12.5.1 McKesson Medical Basic Information
12.5.2 Prophylactic Human Vaccine Product Introduction
12.5.3 McKesson Medical Production, Value, Price, Gross Margin 2015-2020
12.6 Inovio Pharmaceuticals
12.6.1 Inovio Pharmaceuticals Basic Information
12.6.2 Prophylactic Human Vaccine Product Introduction
12.6.3 Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.7 Merck
12.7.1 Merck Basic Information
12.7.2 Prophylactic Human Vaccine Product Introduction
12.7.3 Merck Production, Value, Price, Gross Margin 2015-2020
12.8 Novavax
12.8.1 Novavax Basic Information
12.8.2 Prophylactic Human Vaccine Product Introduction
12.8.3 Novavax Production, Value, Price, Gross Margin 2015-2020
12.9 Sanofi
12.9.1 Sanofi Basic Information
12.9.2 Prophylactic Human Vaccine Product Introduction
12.9.3 Sanofi Production, Value, Price, Gross Margin 2015-2020
12.10 Zoetis
12.10.1 Zoetis Basic Information
12.10.2 Prophylactic Human Vaccine Product Introduction
12.10.3 Zoetis Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Prophylactic Human Vaccine Market Forecast
14.1 Global Prophylactic Human Vaccine Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Inactivated Vaccine Market Value and Volume Forecast (2020-2025)
14.1.2 Attenuated Vaccine Market Value and Volume Forecast (2020-2025)
14.1.3 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Prophylactic Human Vaccine Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Cholera Market Value and Volume Forecast (2020-2025)
14.2.2 Anthrax Market Value and Volume Forecast (2020-2025)
14.2.3 Chicken pox Market Value and Volume Forecast (2020-2025)
14.2.4 Rabies Market Value and Volume Forecast (2020-2025)
14.2.5 Tetanus Market Value and Volume Forecast (2020-2025)
14.2.6 Tuberculosis Market Value and Volume Forecast (2020-2025)
14.2.7 Influenza Market Value and Volume Forecast (2020-2025)
14.2.8 Poliomyelitis Market Value and Volume Forecast (2020-2025)
14.3 Prophylactic Human Vaccine Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
……CONTINUED: